Work

Real-world outcomes among patients with advanced EGFRm NSCLC previously treated with osimertinib and platinum-based chemotherapy.

Year: 2024

Type: conference-abstract

Source: JCO Oncology Practice

DOI: 10.1200/op.2024.20.10_suppl.396

Authors: Jyoti D. Patel, Jie Meng, Hoa Van Le, Marian Eberl, Inaam Haq, Summera Zhou, Boris Gorsh, Stephen Esker, Karen L. Reckamp

Institutions: Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Daiichi Sankyo (Germany), Daiichi Sankyo (United States), Cedars-Sinai Medical Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4402985517

Cites:

Cited by:

Related to: 10